Avantor, Inc. Total Liabilities
Avantor, Inc. (AVTR) had Total Liabilities of $6.07 billion as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-04-29
- 2026-03-31: Liabilities $6.07B.
- 2025-12-31: Liabilities $6.23B.
- 2025-09-30: Liabilities $6.11B.
- 2025-06-30: Liabilities $6.49B.
| Period end | Liabilities |
|---|---|
| 2026-03-31 | $6.07B 10-Q · filed 2026-04-29 |
| 2025-12-31 | $6.23B 10-Q · filed 2026-04-29 |
| 2025-09-30 | $6.11B 10-Q · filed 2025-10-29 |
| 2025-06-30 | $6.49B 10-Q · filed 2025-08-01 |
| 2025-03-31 | $6.23B 10-Q · filed 2025-04-25 |
| 2024-12-31 | $6.16B 10-K · filed 2026-02-11 |
| 2024-09-30 | $7.29B 10-Q · filed 2024-10-25 |
| 2024-06-30 | $7.26B 10-Q · filed 2024-07-26 |
| 2024-03-31 | $7.43B 10-Q · filed 2024-04-26 |
| 2023-12-31 | $7.72B 10-K · filed 2025-02-07 |
| 2023-09-30 | $7.70B 10-Q · filed 2023-10-27 |
| 2023-06-30 | $8.05B 10-Q · filed 2023-07-28 |
| 2023-03-31 | $8.40B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $8.61B 10-K · filed 2024-02-14 |
| 2022-09-30 | $8.52B 10-Q · filed 2022-10-28 |
| 2022-06-30 | $8.96B 10-Q · filed 2022-07-29 |
| 2022-03-31 | $9.48B 10-Q · filed 2022-04-29 |
| 2021-12-31 | $9.70B 10-K · filed 2023-02-14 |
| 2021-09-30 | $8.09B 10-Q · filed 2021-10-29 |
| 2021-06-30 | $8.26B 10-Q · filed 2021-07-30 |
| 2021-03-31 | $6.93B 10-Q · filed 2021-04-28 |
| 2020-12-31 | $7.23B 10-K · filed 2022-02-11 |
| 2020-09-30 | $7.39B 10-Q · filed 2020-10-27 |
| 2020-06-30 | $7.33B 10-Q · filed 2020-07-29 |
| 2020-03-31 | $7.35B 10-Q · filed 2020-04-29 |
| 2019-12-31 | $7.31B 10-K · filed 2021-02-16 |
| 2019-09-30 | $7.41B 10-Q · filed 2019-11-05 |
| 2019-06-30 | $7.61B 10-Q · filed 2019-08-06 |
| 2018-12-31 | $9.10B 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |